Target intelligence / Profile preview

Nanos homolog 2 (NANOS2)

Target
NANOS2
Molecular classification
RNA-binding protein, Zinc finger protein (CCHC-type), Post-transcriptional regulator, Other
01

Overview

Nanos homolog 2 (NANOS2) is an evolutionarily conserved RNA-binding protein required for proper development and maintenance of germ cells, especially in the male germline[1][2][3][5]. It features a unique C2HC-type zinc finger domain structure critical for recognizing and binding specific sequences in the 3′ untranslated region (UTR) of target mRNAs, primarily in spermatogonial stem cells[1][5]. NANOS2 exerts its function mainly by recruiting the CCR4-NOT deadenylation complex to facilitate mRNA deadenylation and degradation, thereby repressing the translation of factors that drive spermatogonial stem cell differentiation and female germ cell fate[2][3][5]. Localization studies show that NANOS2 directs this activity to cytoplasmic P-bodies, the principal sites of mRNA decay. Loss of NANOS2 function results in loss of male germ cells and inappropriate meiosis, linking it to infertility and gonadal dysgenesis. Currently, there are no clinically approved drugs targeting NANOS2, nor are there established mechanisms of action or biomarkers for its inhibition or modulation in therapy.

Other names
Nanos C2HC-type zinc finger 2NOS-2NOS2ZC2HC12BNanos2nanos homolog 2
02

Biological functions

Germ cell developmentSpermatogonial stem cell maintenanceMale germ cell differentiationTranslational repressionRNA degradationRegulation of meiosis
03

Disease associations

Infertility (male)Gonadal dysgenesisOther

Beyond the preview

Go deeper on Nanos homolog 2 (NANOS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nanos homolog 2 (NANOS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call